Refinement of screening for familial pancreatic cancer

Conclusions
It appears safe to start screening for PDAC in IAR of non-CDKN2a FPC families at the age of 50 years. MRI-based screening supplemented by EUS at baseline and every 3rd year or when changes in MRI occur appears to be efficient.

Source: Gut - July 7, 2016 Category: Gastroenterology Authors: Bartsch, D. K., Slater, E. P., Carrato, A., Ibrahim, I. S., Guillen-Ponce, C., Vasen, H. F. A., Matthäi, E., Earl, J., Jendryschek, F. S., Figiel, J., Steinkamp, M., Ramaswamy, A., Vazquez-Sequeiros, E., Munoz-Beltran, M., Montans, J., Mocci, E., Tags: Pancreas and biliary tract, Pancreatic cancer Source Type: research